Regal Assets Analytics

Healthcare

A category of stocks relating to medical and healthcare goods or services. The healthcare sector includes hospital management firms, health maintenance organizations (HMOs), biotechnology and a variety of medical products.

Evolus & Urovant: Similar Strategies, Opposite Reactions to Positive Catalysts

By |2019-03-25T11:45:49-04:00March 25th, 2019|Categories: Bill Langbein, Case Study, Education, Healthcare, Insights, Pharmaceutical & Biotechnology|Tags: , , , , |

One of the strongest performing biopharmaceutical stocks this year is [...]

Verona (VRNA) Talks Up The Long View Following Phase II Setback

By |2019-03-07T14:59:36-04:00January 16th, 2019|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents|Tags: , , , |

Verona Pharma (NASDAQ:VRNA) highlighted a surprising benefit from a lower [...]

ADMA Biologics Believes It Can Resolve CRL Issues Quickly, Spring Review Possible

By |2018-12-28T10:31:02-04:00December 28th, 2018|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents|Tags: , , |

Shares of ADMA Biologics [NASDAQ:ADMA]  fell more than 45% on [...]

ADMA Biologics Receives a Split FDA Decision on BIVIGAM

By |2018-12-20T15:03:58-04:00December 20th, 2018|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents|Tags: , , |

ADMA Biologics (NASDAQ:ADMA), a company specializing in the manufacturing and development [...]

ADMA Biologics (NASDAQ:ADMA) December Catalyst: PDUFA for BIVIGAM

By |2019-01-22T10:02:45-04:00December 13th, 2018|Categories: Bill Langbein, Health Care Equipment & Services, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Probability Sentiment|

SanaCurrents assigns a pivotal sentiment the FDA will approve the [...]

Hemophilia Treatment Company Catalyst Biosciences’ Antibody Update May Catalyze Shares

By |2019-01-22T10:03:35-04:00December 12th, 2018|Categories: Bill Langbein, Health Care Equipment & Services, Healthcare, Insights, Insights-Home, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Probability Sentiment|

Catalyst Biosciences, Inc. (NASDAQ:CBIO) , a company that is developing improved [...]

Karyopharm’s Cancer Drug Achieves Impressive Results

By |2018-12-04T16:07:17-04:00December 2nd, 2018|Categories: Health Care Equipment & Services, Healthcare, Insights, Insights-Home, Pharmaceutical & Biotechnology|Tags: , , , , , |

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) reported impressive results on December 1, 2018 [...]

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) – 3Q 2019 catalyst, CBD treatment for Fragile X

By |2019-01-22T10:03:50-04:00November 21st, 2018|Categories: Bill Langbein, Health Care Equipment & Services, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Probability Sentiment|Tags: , , , , |

3Q ‘19 catalyst, CBD treatment for Fragile X SanaCurrents is [...]